The impact of COVID-19 pandemic on headache symptoms and drug withdrawal among patients with medication overuse headache: a cross-sectional study.
Changling LiYanbo LiMengmeng MaYang ZhangJiajia BaoWenjing GeYanqin LiuCheng PengLi HePublished in: The journal of headache and pain (2021)
Our findings reflect that MOH patients experienced a worse relief of headache symptoms and drug withdrawal during the pandemic. Available access to regular prophylactic medications was the significant independent factor for improvement of headache symptoms. Male sex was significantly associated with decreased days with acute medications per month.
Keyphrases
- end stage renal disease
- drug induced
- chronic kidney disease
- sleep quality
- newly diagnosed
- ejection fraction
- sars cov
- adverse drug
- healthcare
- liver failure
- coronavirus disease
- peritoneal dialysis
- prognostic factors
- emergency department
- respiratory failure
- patient reported outcomes
- hepatitis b virus
- intensive care unit
- patient reported